Lateral flow assay HIV-based microfluidic blood fuel cell

6Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This work presents the integration, evaluation and performance of a lateral flow assay HIV-based microfluidic fuel cell. To integrate the microfluidic fuel cell, a Pt/C cathode and Au/C anode were deposited on Toray® paper and stacked on the top and bottom, respectively, of the paper strip lateral flow assay HIV. According to the microfluidic fuel cell evaluation, the Pt/C cathode reduces the oxygen delivered from air, meanwhile the Au/C anode oxidizes the glucose contained in the human blood. The lateral flow assay HIV-based microfluidic blood fuel cell (LFA HIV-based μBFC) performance showed power density of 0.15 mW cm -2 . The open circuit voltage and maximum current density were 0.57 V and 1.2 mA cm -2 , respectively. Furthermore, the LFA HIV-based μBFC showed a constant current density for 10 minutes at a potential corresponding to the maximum power density. In this sense, is demonstrated that lateral flow assay towards an autonomous energy device is a great advance to be applied in point-of-care testing.

Cite

CITATION STYLE

APA

Olivares-Ramírez, J. M., Ovando-Medina, V. M., Ortíz-Verdín, A., Amaya-Cruz, D. M., Coronel-Hernandez, J., Marroquín, A., & Dector, A. (2018). Lateral flow assay HIV-based microfluidic blood fuel cell. In Journal of Physics: Conference Series (Vol. 1119). Institute of Physics Publishing. https://doi.org/10.1088/1742-6596/1119/1/012022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free